Well all jokes aside, we may all be calling that number if the share price keeps performing the way it is ! Without question one of the most positive announcements in the company's history, US Govt & FDA have given doctors a license to print money in the biggest market in the world through RPM to keep the pressure off doctor's waiting rooms, emergency departments, hospital beds after the tragic experiences with COVID. Wheezo is one of few approved and reimbursed medical devices in respiratory diseases, distributors falling over themselves to add it to their product mix, minimal set up and marketing costs required for RSH to establish it's footprint and the investment community here does not respond!! It beggars belief, what is Investor Relations doing ? How is the message not cutting through ?
RSH Price at posting:
4.7¢ Sentiment: Buy Disclosure: Held
